By Trevor Damyan, Commercial Mortgage Broker at Commercial Lending Solutions
Cannabis real estate financing exists in a specialized parallel CRE financing market because federal Schedule I status keeps banks, agencies, CMBS, and most life cos out of the asset class. State-legal cannabis operators (in California, Colorado, Oregon, Washington, Nevada, Arizona, Massachusetts, New York, New Jersey, Illinois, Michigan, Maryland, New Mexico, Montana, Connecticut, Rhode Island, Missouri, Ohio, and Florida medical) access real estate capital through a narrow but growing bench of specialty cannabis REITs (Innovative Industrial Properties, NewLake Capital, Power REIT, AFC Gamma), private credit funds, and a small number of cannabis-friendly state-chartered banks and credit unions. Financing typically runs at 350 to 700 basis points wide of comparable conventional CRE due to federal regulatory risk, limited lender competition, and operating volatility.
Get a Cannabis CRE Quote →Cannabis real estate capital comes from four primary channels: cannabis REITs that purchase real estate from operators and lease it back (sale-leaseback model), specialty cannabis private credit funds that lend on the real estate, a small number of cannabis-friendly state-chartered banks and credit unions that lend at the loan size minimum, and the limited subset of life cos and CMBS lenders willing to underwrite cannabis-adjacent properties (typically processing or laboratory tenants in industrial-zoned facilities).
Pricing is indicative and reflects active CLS CRE quote pipeline as of April 2026. Actual pricing depends on property condition, sponsor profile, deal size, and market dynamics.
Cultivation real estate transactions range from $2M for small craft cultivation in mature legal markets to $50M+ for large-scale Tier 3 cultivation facilities (50,000+ square feet) in newer state-legal markets. Per-square-foot cultivation real estate values vary enormously by market and license scarcity: a Massachusetts adult-use cultivation facility might trade at $400 to $700 per square foot, while a California cultivation facility in an over-supplied market might trade at $150 to $300 per square foot.
Dispensary real estate is a much smaller transaction profile: typical $1.5M to $5M for a single dispensary location in a state with limited license counts. License-tied real estate (where the license cannot legally operate at a different location without state approval) commands premium values reflecting the embedded license value.
Processing and laboratory facilities range from $3M to $25M depending on scale and equipment. Extraction labs, edibles manufacturing, and hash-product processing all have specific facility design requirements (Class 1 Division 1 electrical, ventilation, fire suppression, building code) that drive both capital cost and lender appetite.
Vertically integrated multi-state operators (MSOs) increasingly use sale-leaseback to free up capital from real estate. The MSO sells its real estate to a cannabis REIT or private buyer at a stated cap rate and leases the property back under a long-term triple-net lease, typically 15 to 20 years. The freed-up capital funds expansion, operations, or balance sheet.
Cannabis real estate underwriting evaluates the property, the operating tenant (or operator-borrower), the state regulatory environment, and the federal regulatory risk in equal weight. The asset class requires lender sophistication that most CRE lenders lack, which is why the active lender bench is narrow.
Cannabis real estate transactions have specific failure modes that catch first-time sponsors and even experienced cannabis operators new to capital markets. The most common pitfalls cluster around federal regulatory risk, state market saturation, and lender expectations on operator transparency.
On a $14M acquisition of a 65,000 square foot cultivation facility in a limited-license adult-use state, the sponsor was a vertically integrated single-state operator with an established license and three years of operating history. The deal was structured as a sale-leaseback through a cannabis REIT: the REIT acquired the property at a 10.5 percent initial cap rate, and the operator leased it back under a 20-year triple-net lease with 3.0 percent annual escalations and a corporate guaranty from the operating company plus a personal guaranty from the principal owner. The freed-up $14M of capital funded a planned expansion of cultivation capacity and dispensary acquisition in an adjacent state. The transaction closed in 95 days from term sheet, with extensive REIT due diligence on operating history, license compliance, and corporate structure. The triple-net structure removed property tax, insurance, and capital expenditure responsibility from the operator and locked in occupancy cost as a defined operating expense.
All deal references anonymize borrower and lender identities and use city-level geography only.
Cannabis real estate financing is one of the highest-cost-of-capital corners of CRE because federal Schedule I status keeps the cheapest capital pools out of the asset class. The good news is that the specialty bench is real, the products are well-defined, and operators who plan capital structure deliberately can access financing at competitive specialty terms.
Tell us about your cannabis cre deal. We will run it past lenders that actively fund this property type and send back terms within 48 hours.
Apply for Financing →